Related Experiment Video
Updated: Jul 31, 2026

A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood
Published on: February 8, 2016
Model selection methodology for inter-laboratory standardisation of antibody titres
George Kafatos1, Nick Andrews, Anthony Nardone
1Statistics Unit, Communicable Disease Surveillance Centre, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, UK. george.kafatos@hpa.org.uk
The European Sero-Epidemiology Network 2 (ESEN2) developed a robust algorithm to standardize serological results for vaccine-preventable diseases across Europe. This method allows for reliable international comparisons of immune status by adjusting for laboratory variations.
Area of Science:
- Immunology
- Epidemiology
- Public Health
Background:
- Comparing serological results for vaccine-preventable diseases across European countries is challenging due to laboratory and assay variability.
- Standardized serological data is crucial for accurate epidemiological assessments and public health policy in Europe.
Purpose of the Study:
- To establish a standardized method for comparing serological results of vaccine-preventable diseases across Europe.
- To develop and validate an algorithm for creating standardization equations to adjust for laboratory and assay differences.
Main Methods:
- Participant laboratories tested a standardization panel for each disease.
- Results were plotted against a reference center to derive standardization equations.
- A robust algorithm was developed to account for outliers, censored data, and model selection.
Main Results:
- Standardization equations were successfully generated to adjust for laboratory and assay variations.
- The algorithm proved robust across various assays and diseases.
- Conversion of country-specific serum bank results to a common unitage was achieved where equations explained sufficient variability.
Conclusions:
- The developed algorithm provides a robust method for standardizing serological results across different laboratories and assays.
- This standardization enables reliable international comparisons of vaccine-preventable disease seroprevalence in Europe.
- The ESEN2 approach facilitates more accurate public health surveillance and policy-making.
More Related Videos
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
06:15Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018